These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15932265)

  • 1. Pilot-scale adenovirus seed production through concurrent virus release and concentration by hollow fiber filtration.
    Subramanian S; Altaras GM; Chen J; Hughes BS; Zhou W; Altaras NE
    Biotechnol Prog; 2005; 21(3):851-9. PubMed ID: 15932265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification.
    Wickramasinghe SR; Kalbfuss B; Zimmermann A; Thom V; Reichl U
    Biotechnol Bioeng; 2005 Oct; 92(2):199-208. PubMed ID: 16041807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-free suspension cultivation of PER.C6(R) cells and recombinant adenovirus production under different pH conditions.
    Xie L; Pilbrough W; Metallo C; Zhong T; Pikus L; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2002 Dec; 80(5):569-79. PubMed ID: 12355468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
    Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector.
    Maranga L; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2005 Jun; 90(5):645-55. PubMed ID: 15834950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.
    Subramanian S; Kim JJ; Harding F; Altaras GM; Aunins JG; Zhou W
    Biotechnol Prog; 2007; 23(5):1210-7. PubMed ID: 17715941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closed hollow-fiber bioreactor: a new approach to retroviral vector production.
    Pan D; Whitley CB
    J Gene Med; 1999; 1(6):433-40. PubMed ID: 10753069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
    Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
    J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of baboon endogenous virus in large-scale production by use of hollow-fiber ultrafiltration technology.
    Weiss SA
    Biotechnol Bioeng; 1980 Jan; 22(1):19-31. PubMed ID: 6766070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
    Gramer MJ; Maas J
    Biotechnol Prog; 2003; 19(6):1762-6. PubMed ID: 14656153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA.
    Goerke AR; To BC; Lee AL; Sagar SL; Konz JO
    Biotechnol Bioeng; 2005 Jul; 91(1):12-21. PubMed ID: 15889400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of solution pH on protein transmission and membrane capacity during virus filtration.
    Bakhshayeshi M; Zydney AL
    Biotechnol Bioeng; 2008 May; 100(1):108-17. PubMed ID: 18080342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards purification of adenoviral vectors based on membrane technology.
    Peixoto C; Ferreira TB; Sousa MF; Carrondo MJ; Alves PM
    Biotechnol Prog; 2008; 24(6):1290-6. PubMed ID: 19194943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
    Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different serum-free media and osmolality effect upon human 293 cell growth and adenovirus production.
    Ferreira TB; Ferreira AL; Carrondo MJ; Alves PM
    Biotechnol Lett; 2005 Nov; 27(22):1809-13. PubMed ID: 16314975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines.
    Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U
    Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2 ultrafiltration systems for the concentration of seeded viruses from environmental waters.
    Olszewski J; Winona L; Oshima KH
    Can J Microbiol; 2005 Apr; 51(4):295-303. PubMed ID: 15980891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of higher passage PER.C6 cells for adenovirus manufacture.
    Berdichevsky M; Gentile MP; Hughes B; Meis P; Peltier J; Blumentals I; Auniņs J; Altaras NE
    Biotechnol Prog; 2008; 24(1):158-65. PubMed ID: 18052336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.